Showing results (11-20 of 111) with videos related to
Sort By:
Pageof 12
International Journal of Laboratory Hematology|November 2, 2018
Apoptosis: A biomarker of high-risk phenotype in pediatric acute myeloid leukemia?Anudishi Tyagi, Raja Pramanik, Radhika Bakhshi, et al.Oncotarget|March 14, 2019
Prognostic impact of mitochondrial DNA D-loop variations in pediatric acute myeloid leukemiaAnudishi Tyagi, Raja Pramanik, Sreenivas Vishnubhatla, et al.BMJ Neurology Open|November 29, 2023
Efficacy of exercises in early-stage Parkinson's disease (PARK-EASE trial): single-blind, randomised, controlled trialRaktim Swarnakar, Sanjay Wadhwa, Srikumar Venkataraman, et al.Journal of Pediatric Genetics|November 6, 2019
Genetic Landscape of Mitochondrial Regulatory Region in Pediatric Acute Myeloid Leukemia: Changes from Diagnosis to RelapseAnudishi Tyagi, Raja Pramanik, Radhika Bakhshi, et al.Pediatric Blood & Cancer|July 17, 2020
Outpatient ADE (cytarabine, daunorubicin, and etoposide) is feasible and effective for the first relapse of pediatric acute myeloid leukemia: A prospective, phase II studyArun Garg, Shuvadeep Ganguly, Sreenivas Vishnubhatla, et al.Neuroscience Letters|November 16, 2020
A combinatorial approach to modulate microenvironment toward regeneration and repair after spinal cord injury in ratsSupti Bhattacharyya, Amit Dinda, Sreenivas Vishnubhatla, et al.The Laryngoscope|October 28, 2014
Prognostic factors in head and neck Ewing sarcoma family of tumorsBivas Biswas, Alok Thakar, Bidhu K Mohanti, et al.Pediatric Hematology and Oncology|February 7, 2014
FLT3-ITD mutation in relation to FLT3 expression in pediatric AML: a prospective study from IndiaSurender Kumar Sharawat, Radhika Bakhshi, Sreenivas Vishnubhatla, et al.Brain Stimulation|April 15, 2020
A randomized, double blind, sham-controlled trial of repetitive transcranial magnetic stimulation (rTMS) in the treatment of negative symptoms in schizophreniaNand Kumar, Sreenivas Vishnubhatla, Ashima Nehra Wadhawan, et al.Pediatric Blood & Cancer|April 5, 2013
BAX/BCL2 RMFI ratio predicts better induction response in pediatric patients with acute myeloid leukemiaSurender Kumar Sharawat, Radhika Bakhshi, Sreenivas Vishnubhatla, et al.Pageof 12